Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230684 · ClinicalTrials.gov registry record · NA
Contrast Enhanced Ultrasound vs. Computed Tomographic Angiography in the Detection of Endoleaks Following AAA Repair
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01230684 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 4 participants.
The verdict
NCT01230684, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the study is to compare two different types of imaging techniques to identify endoleaks. Following the endovascular procedure, subjects are seen at one month to have computed tomographic angiography (CTA) to confirm the graft is not leaking (endoleak). CTA is the standard imaging technique used to identify endoleaks. This study will investigate if the image technique color duplex ultrasound with contrast enhanced ultrasound (CEUS) is a good tool to identify endoleaks too.
Interventions
- PROCEDURE Contrast Enhanced Ultrasound (Contrast Agent: OptisonTM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01230684
The ClinicalTrials.gov registry entry for NCT01230684 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contrast Enhanced Ultrasound (Contrast Agent: OptisonTM) is the first listed.
NCT01230684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01230684 about?
NCT01230684 is a clinical study titled "Contrast Enhanced Ultrasound vs. Computed Tomographic Angiography in the Detection of Endoleaks Following AAA Repair". The purpose of the study is to compare two different types of imaging techniques to identify endoleaks. Following the endovascular procedure, subjects are seen at one month to have computed tomographic angiography (CTA) to confirm the graft is not leaking (endoleak). CTA is the standard imaging tech...
What is the current status of trial NCT01230684?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2010-12. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01230684?
The interventions under investigation include: Contrast Enhanced Ultrasound (Contrast Agent: OptisonTM) (PROCEDURE).
Who is sponsoring clinical trial NCT01230684?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.